1. Home
  2. ODC vs DSGN Comparison

ODC vs DSGN Comparison

Compare ODC & DSGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ODC
  • DSGN
  • Stock Information
  • Founded
  • ODC 1941
  • DSGN 2017
  • Country
  • ODC United States
  • DSGN United States
  • Employees
  • ODC N/A
  • DSGN N/A
  • Industry
  • ODC Miscellaneous manufacturing industries
  • DSGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • ODC Consumer Discretionary
  • DSGN Health Care
  • Exchange
  • ODC Nasdaq
  • DSGN Nasdaq
  • Market Cap
  • ODC 310.1M
  • DSGN 348.2M
  • IPO Year
  • ODC N/A
  • DSGN 2021
  • Fundamental
  • Price
  • ODC $42.39
  • DSGN $5.06
  • Analyst Decision
  • ODC
  • DSGN Hold
  • Analyst Count
  • ODC 0
  • DSGN 3
  • Target Price
  • ODC N/A
  • DSGN $7.00
  • AVG Volume (30 Days)
  • ODC 39.8K
  • DSGN 220.6K
  • Earning Date
  • ODC 03-06-2025
  • DSGN 03-18-2025
  • Dividend Yield
  • ODC 1.46%
  • DSGN N/A
  • EPS Growth
  • ODC 36.22
  • DSGN N/A
  • EPS
  • ODC 3.09
  • DSGN N/A
  • Revenue
  • ODC $454,094,000.00
  • DSGN N/A
  • Revenue This Year
  • ODC N/A
  • DSGN N/A
  • Revenue Next Year
  • ODC N/A
  • DSGN N/A
  • P/E Ratio
  • ODC $13.78
  • DSGN N/A
  • Revenue Growth
  • ODC 6.61
  • DSGN N/A
  • 52 Week Low
  • ODC $29.48
  • DSGN $2.25
  • 52 Week High
  • ODC $46.50
  • DSGN $7.77
  • Technical
  • Relative Strength Index (RSI)
  • ODC 54.18
  • DSGN 44.20
  • Support Level
  • ODC $43.48
  • DSGN $3.71
  • Resistance Level
  • ODC $42.45
  • DSGN $6.81
  • Average True Range (ATR)
  • ODC 1.22
  • DSGN 0.49
  • MACD
  • ODC -0.34
  • DSGN -0.14
  • Stochastic Oscillator
  • ODC 42.30
  • DSGN 43.55

About ODC Oil-Dri Corporation Of America

Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups namely Retail and Wholesale Products Group and Business to Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.

About DSGN Design Therapeutics Inc.

Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.

Share on Social Networks: